
2025 United States 2D Cell Culture Market Revenue Opportunities Report
Description
The 2025 United States 2D Cell Culture Market Revenue Opportunities Report features 1) market size data for the region or country, 2) annual market growth rates, 3) the market's impact on related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing, 4) Total Addressable Market (TOM) for the four largest market players, 5) Serviceable Addressable Market (SAM), and 6) Serviceable Obtainable Market (SOM)(Wharry Sharpe Research)
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the 2D Cell Culture Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the 2D Cell Culture market in the United States are Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, and Lonza Group AG. Thermo Fisher Scientific leads with a comprehensive range of cell culture products, including innovative media and automated systems, positioning itself as a dominant market player with recent releases like stem cell-specific serum-free media in 2025. Merck KGaA has expanded its U.S. production capacity to meet rising demand and collaborates on novel cell line developments. Corning focuses on advanced cell culture technologies, including microcarrier-based 3D culture systems for vaccine production. Lonza offers extensive cell culture systems and benefits from strategic partnerships to expand its market presence.
These companies are driving market growth through innovation, strategic collaborations, and product diversification. Thermo Fisher’s launch of advanced biotherapeutic media and automated culture systems exemplifies its R&D focus. Merck KGaA’s facility expansions reflect its commitment to scalable, high-quality media production. Corning’s latest technologies enhance efficiency and output for biopharma applications. Lonza’s acquisitions and partnerships strengthen its global footprint, supporting diverse research and pharmaceutical clients. Together, they shape a competitive landscape characterized by technological advances and increasing demand for reliable, cost-effective 2D cell culture solutions in the U.S..
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
The Revenue Opportunities Reports provide market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for the region or country. The report also features written analysis on market definitions, and market segments.
Market and product shipments include the total value of all products produced and shipped by all producers (also described as value of receipts, value of production, or value of work done.)
The report features written analysis and market size statistics on opportunities created in the 2D Cell Culture Market by the changing related industries Medical and Surgical Hospitals, Offices of Physicians, and Medical Device Manufacturing,
The four largest companies actively participating in the 2D Cell Culture market in the United States are Thermo Fisher Scientific, Merck KGaA, Corning Incorporated, and Lonza Group AG. Thermo Fisher Scientific leads with a comprehensive range of cell culture products, including innovative media and automated systems, positioning itself as a dominant market player with recent releases like stem cell-specific serum-free media in 2025. Merck KGaA has expanded its U.S. production capacity to meet rising demand and collaborates on novel cell line developments. Corning focuses on advanced cell culture technologies, including microcarrier-based 3D culture systems for vaccine production. Lonza offers extensive cell culture systems and benefits from strategic partnerships to expand its market presence.
These companies are driving market growth through innovation, strategic collaborations, and product diversification. Thermo Fisher’s launch of advanced biotherapeutic media and automated culture systems exemplifies its R&D focus. Merck KGaA’s facility expansions reflect its commitment to scalable, high-quality media production. Corning’s latest technologies enhance efficiency and output for biopharma applications. Lonza’s acquisitions and partnerships strengthen its global footprint, supporting diverse research and pharmaceutical clients. Together, they shape a competitive landscape characterized by technological advances and increasing demand for reliable, cost-effective 2D cell culture solutions in the U.S..
Revenue Opportunities are defined by the measurements of Total Addressable Market (TOM) for the four largest market players, Serviceable Addressable Market (SAM), and Serviceable Obtainable Market (SOM). The measurements include both written analysis and current calculations for each company in the market for each country or region.
This report does not provide the names of companies in the market or written analysis of each market's trends within each country to provide a cost-effective report that focuses solely on the statistics and data on each market.
Wharry Sharpe Research publishes thousands of market analysis and product research report annually to assist their clients with the essential data they need for the market research, budgeting and forecasting needs.
Table of Contents
51 Pages
- A. Definitions
- A1. Market Definition
- A2. Market Segmentation
- A3. Industry Opportunities-Industry1
- A4. Industry Opportunities-Industry2
- A5. Industry Opportunities-Industry3
- B. Total Addressable Market (TAM)
- B1. TAM-Player 1/4
- B2. TAM-Player 2/4
- B3. TAM-Player 3/4
- B4. TAM-Player 4/4
- C. Serviceable Addressable Market (SAM)
- C1. SAM-Player 1/4
- C2. SAM-Player 2/4
- C3. SAM-Player 3/4
- C4. SAM-Player 4/4
- D. Serviceable Obtainable Market (SOM)
- D1. SOM-Player 1/4
- D2. SOM-Player 2/4
- D3. SOM-Player 3/4
- D4. SOM-Player 4/4
- E. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.